ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.53
1.40%
US Tech 100
17,598.80
1.03%
S&P 500
5,180.74
1.03%
US Dollar vs CAD
1.36791
0.06%
Bitcoin
63,379.09
0.34%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cardiff Oncology Inc (CRDF)

  7. Cardiff Oncology Inc (CRDF) News

CRDF

Cardiff Oncology (CRDF)

Cardiff Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRDF
DateTimeSourceHeadlineSymbolCompany
05/02/20243:05PMGlobeNewswire Inc.Cardiff Oncology Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
04/25/20243:05PMGlobeNewswire Inc.Cardiff Oncology to Report First Quarter 2024 Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
04/08/20243:05PMGlobeNewswire Inc.Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical StudyNASDAQ:CRDFCardiff Oncology Inc
03/07/20245:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/07/20245:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/07/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/07/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRDFCardiff Oncology Inc
03/06/20243:05PMGlobeNewswire Inc.Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024NASDAQ:CRDFCardiff Oncology Inc
02/29/20243:07PMGlobeNewswire Inc.Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
02/29/20243:06PMGlobeNewswire Inc.Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRCNASDAQ:CRDFCardiff Oncology Inc
02/29/20243:05PMGlobeNewswire Inc.Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)NASDAQ:CRDFCardiff Oncology Inc
02/29/20243:00PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRDFCardiff Oncology Inc
02/26/20247:00AMGlobeNewswire Inc.Cardiff Oncology to Present at the Cowen 44th Annual Health Care ConferenceNASDAQ:CRDFCardiff Oncology Inc
02/22/20247:00AMGlobeNewswire Inc.Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
02/06/20243:01PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRDFCardiff Oncology Inc
01/17/20249:30AMPR Newswire (US)Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer ResearchNASDAQ:CRDFCardiff Oncology Inc
01/08/20248:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
11/20/20233:05PMPR Newswire (US)Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:CRDFCardiff Oncology Inc
11/02/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
11/02/20233:05PMPR Newswire (US)Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
11/02/20233:02PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRDFCardiff Oncology Inc
10/26/20233:05PMPR Newswire (US)Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business UpdateNASDAQ:CRDFCardiff Oncology Inc
09/26/20233:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
09/26/20233:05PMPR Newswire (US)Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib MonotherapyNASDAQ:CRDFCardiff Oncology Inc
09/05/20237:00AMPR Newswire (US)Cardiff Oncology to Present at Upcoming Investor Conferences in SeptemberNASDAQ:CRDFCardiff Oncology Inc
08/09/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
08/09/20233:05PMPR Newswire (US)Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business UpdateNASDAQ:CRDFCardiff Oncology Inc
08/09/20233:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRDFCardiff Oncology Inc
08/07/20233:42PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRDFCardiff Oncology Inc
08/07/20233:05PMPR Newswire (US)Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer RelationshipNASDAQ:CRDFCardiff Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CRDF

Your Recent History

USOTC
INKW
Greene Concepts (PK)
USOTC
MVNT
Movement Industries (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
SFLM
SFLMaven (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
MULN
Mullen Automotive
USOTC
INND
Innerscope Hearing Techn... (PK)
USOTC
AFFU
Affluence (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
ALYI
Alternet Systems (PK)
USOTC
AHRO
Authentic (CE)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
ILST
International Star (PK)
USOTC
ENZC
Enzolytics (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved